AI assistant
Sending…
Enlivex Therapeutics Ltd. — Audit Report / Information 2019
Jul 17, 2019
6778_rns_2019-07-17_0e6bf088-bf1f-4299-b096-3e35a625653a.htm
Audit Report / Information
Open in viewerOpens in your device viewer
_________ false
| �������� ��������� ��"� | 2 365 |
| ENLIVEX THERAPEUTICS LTD | |
| Corporation no: 514716489 | 12568 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C307 ( Public ) | Reported via MAGNA: | 17/07/2019 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2019-02-073381 | Time of broadcast: 12:15 12:13:45 |
Initial Details of Accountant
As of the date of this report, the details of the corporation's accountant are as follows:
| 1. Name of accountant: | BKR | Yarel + Partners |
2. Date on which he began his term of office: 17/03/2019
| 3. Address: | 1 Nirim st., Tel-Aviv 6706036, Israel |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 25/06/2019 |
| Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070 | |
| E-mail address: [email protected] Company site: www.enlivex.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D | |
| Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: [email protected] 2 | |
| ISRAEL |
More from Enlivex Therapeutics Ltd.
Report Publication Announcement
2026
Apr 21
Capital/Financing Update
2026
Apr 21
Regulatory Filings
2026
Apr 21
Report Publication Announcement
2026
Apr 21
Report Publication Announcement
2026
Apr 8
Regulatory Filings
2026
Apr 8
Delisting Announcement
2026
Apr 5
Earnings Release
2026
Mar 26
Regulatory Filings
2026
Mar 26
Report Publication Announcement
2026
Mar 26